Sub-Saharan Africa

Aspen’s presence in SSA is through its wholly owned subsidiaries, Shelys (Tanzania), Beta Healthcare International (Kenya), Beta Healthcare (Uganda) and Aspen Nigeria. Aspen also has a 65% shareholding in Kama (Ghana) and exports products from South Africa into selected territories. While it was agreed to terminate the SSA Collaboration between Aspen and GSK after the 2016 year end close, the SSA Collaboration was an important contributor to the revenue of this region for the 2016 financial year. Aspen uses its own sales representation and distribution infrastructure across the region to supply a range of high quality pharmaceutical products. Aspen has its own operations in Nigeria, Ghana, Kenya, Tanzania, and Uganda, with the rest of the region being serviced through long-standing relationships with local distributors supported by sales representatives. Aspen supplies a range of branded, generic, OTC, consumer health and infant nutritional products into SSA.

BUSINESS UNIT OVERVIEW

Sub-Saharan Africa

Key business units

Aspen Nigeria
Beta Kenya
Beta Uganda

Exports division
Kama
Shelys

The SSA Collaboration

Key countries supplied to in this region

• Angola • Botswana • Ethiopia • Ghana • Ivory Coast • Kenya • Mauritius • Namibia
• Nigeria • Tanzania • Uganda • Zambia • Zimbabwe

• Revenue from Aspen-owned brands improved 25%.

• Strong working capital management resulting in dividends being declared by all business units, except Kama.

• Strong financial performance from Kama in the first full year of control.

• Aspen enjoys representation in most SSA countries through its own sales force and a network of more than 200 distributors.

• Aspen is among the leading companies in antibiotics, respiratory, pain, cough and cold segments throughout SSA.

• Shelys received the “Presidential Manufacturer of the Year” Award for 2015 under the pharmaceutical and medical equipment, large-scale category.

Contribution to Group
comparable gross revenue

Contribution to Group
comparable EBITA

Number of products launched from pipeline:

44 (2015: 19)

IMS value of pipeline as at 30 June 2016 anticipated to be launched in:

Not covered by IMS​​​​​​​

Number of permanent employees:

427 (2015: 408)

Average staff turnover:

21% (2015: 11%)

Number of product recalls:

Nil (2015: Nil)

Number of work-related fatalities:

Nil (2015: Nil)

Carbon emissions:

Scope 1:
2 349 tCO2e
(2015: 2 431 tCO2e)
Scope 2:
2 326 tCO2e
(2015: 2 300 tCO2e)